89 related articles for article (PubMed ID: 2312037)
21. Chronic atrophic gastritis and Helicobacter pylori infection in primary biliary cirrhosis: a cross-sectional study with matching.
Floreani A; Biagini MR; Zappalà F; Farinati F; Plebani M; Rugge M; Surrenti C; Naccarato R
Ital J Gastroenterol Hepatol; 1997 Feb; 29(1):13-7. PubMed ID: 9265572
[TBL] [Abstract][Full Text] [Related]
22. Clinical and biochemical features and therapy responses in primary biliary cirrhosis and primary biliary cirrhosis-autoimmune hepatitis overlap syndrome.
Günsar F; Akarca US; Ersöz G; Karasu Z; Yüce G; Batur Y
Hepatogastroenterology; 2002; 49(47):1195-200. PubMed ID: 12239904
[TBL] [Abstract][Full Text] [Related]
23. Hepatocellular carcinoma in primary biliary cirrhosis and its impact on outcomes.
Jones DE; Metcalf JV; Collier JD; Bassendine MF; James OF
Hepatology; 1997 Nov; 26(5):1138-42. PubMed ID: 9362353
[TBL] [Abstract][Full Text] [Related]
24. Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: clinical features and response to therapy.
Chazouillères O; Wendum D; Serfaty L; Montembault S; Rosmorduc O; Poupon R
Hepatology; 1998 Aug; 28(2):296-301. PubMed ID: 9695990
[TBL] [Abstract][Full Text] [Related]
25. [Clinical and pathological analysis on characteristics of primary biliary cirrhosis].
Zhou GD; Zhao JM; Wang SS; Sun YL; Meng EH; Zhang TH; Liu P
Zhonghua Gan Zang Bing Za Zhi; 2003 Aug; 11(8):483-6. PubMed ID: 12939182
[TBL] [Abstract][Full Text] [Related]
26. Methotrexate therapy in primary biliary cirrhosis.
Sordá J; Findor J
Acta Gastroenterol Latinoam; 2000; 30(4):221-5. PubMed ID: 11086511
[TBL] [Abstract][Full Text] [Related]
27. Long-term follow-up after recurrence of primary biliary cirrhosis after liver transplantation in 100 patients.
Jacob DA; Neumann UP; Bahra M; Klupp J; Puhl G; Neuhaus R; Langrehr JM
Clin Transplant; 2006; 20(2):211-20. PubMed ID: 16640529
[TBL] [Abstract][Full Text] [Related]
28. Prolonged treatment with ursodeoxycholic acid for primary biliary cirrhosis.
Crippa G; Cagnoni C; Castelli A; Concesi C; Girometta S; Pancotti D; Sverzellati E; Tacchini G; Pierfranceschi MG; Carrara GC
Clin Ter; 1995 May; 146(5):367-72. PubMed ID: 7796569
[TBL] [Abstract][Full Text] [Related]
29. [Primary biliary cirrhosis (PBC)-CREST overlap syndrome complicated with Sjögren's syndrome].
Akiyama Y; Suzuki T; Tanaka M; Fujimaki T; Asaoka T; Kobayashi K; Ohno S; Imai F; Matuo H
Ryumachi; 1997 Feb; 37(1):42-7. PubMed ID: 9128423
[TBL] [Abstract][Full Text] [Related]
30. Long-term survival and impact of ursodeoxycholic acid treatment for recurrent primary biliary cirrhosis after liver transplantation.
Charatcharoenwitthaya P; Pimentel S; Talwalkar JA; Enders FT; Lindor KD; Krom RA; Wiesner RH
Liver Transpl; 2007 Sep; 13(9):1236-45. PubMed ID: 17763401
[TBL] [Abstract][Full Text] [Related]
31. A randomized trial comparing colchicine and ursodeoxycholic acid combination to ursodeoxycholic acid in primary biliary cirrhosis. UDCA-PBC Study Group.
Poupon RE; Huet PM; Poupon R; Bonnand AM; Nhieu JT; Zafrani ES
Hepatology; 1996 Nov; 24(5):1098-103. PubMed ID: 8903382
[TBL] [Abstract][Full Text] [Related]
32. [Primary biliary cirrhosis: an analysis of 153 cases].
Chen G; Li L; Gao J; Li F; Li B
Zhonghua Yi Xue Za Zhi; 2002 Dec; 82(23):1625-8. PubMed ID: 12667372
[TBL] [Abstract][Full Text] [Related]
33. Plasma separation and anion adsorption transiently relieve intractable pruritus in primary biliary cirrhosis.
Pusl T; Denk GU; Parhofer KG; Beuers U
J Hepatol; 2006 Dec; 45(6):887-91. PubMed ID: 17046095
[TBL] [Abstract][Full Text] [Related]
34. Combined treatment with ursodeoxycholic acid and prednisone in primary biliary cirrhosis.
Wolfhagen FH; van Buuren HR; Schalm SW
Neth J Med; 1994 Mar; 44(3):84-90. PubMed ID: 8202208
[TBL] [Abstract][Full Text] [Related]
35. Therapeutic efficacy of decreased nitrite production by bezafibrate in patients with primary biliary cirrhosis.
Akbar SM; Furukawa S; Nakanishi S; Abe M; Horiike N; Onji M
J Gastroenterol; 2005 Feb; 40(2):157-63. PubMed ID: 15770399
[TBL] [Abstract][Full Text] [Related]
36. [Immunological characteristics of primary biliary cirrhosis patients].
Yan HP; Zhuang H; Liu YM; Feng X; Tan YF; Liu Y; Zhang X; Zhao CH
Zhonghua Gan Zang Bing Za Zhi; 2005 Jan; 13(1):12-6. PubMed ID: 15670483
[TBL] [Abstract][Full Text] [Related]
37. The clinical effectiveness and safety of chronic plasmapheresis in patients with primary biliary cirrhosis.
Ambinder EP; Cohen LB; Wolke AM; Field SP; Adelsberg B; Schaffner F; Zaroulis CG
J Clin Apher; 1985; 2(3):219-23. PubMed ID: 4030709
[TBL] [Abstract][Full Text] [Related]
38. Diagnosis and treatment of primary biliary cirrhosis.
Nishio A; Keeffe EB; Ishibashi H; Gershwin EM
Med Sci Monit; 2000; 6(1):181-93. PubMed ID: 11208308
[TBL] [Abstract][Full Text] [Related]
39. Antimitochondrial antibody-negative primary biliary cirrhosis: a subset of primary biliary cirrhosis.
Liu B; Shi XH; Zhang FC; Zhang W; Gao LX
Liver Int; 2008 Feb; 28(2):233-9. PubMed ID: 18251980
[TBL] [Abstract][Full Text] [Related]
40. Prevalence of immune disturbances and chronic liver disease in family members of patients with primary biliary cirrhosis.
Bittencourt PL; Farias AQ; Abrantes-Lemos CP; Goncalves LL; Goncalves PL; Magalhães EP; Carrilho FJ; Laudanna AA; Cançado EL
J Gastroenterol Hepatol; 2004 Aug; 19(8):873-8. PubMed ID: 15242489
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
